NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,733,834 | -42.5% | 246,275 | -24.0% | 0.00% | -33.3% |
| Q2 2023 | $8,234,567 | -37.1% | 323,937 | -10.5% | 0.00% | -25.0% |
| Q1 2023 | $13,087,037 | +540686.7% | 362,023 | +492.1% | 0.00% | +300.0% |
| Q4 2022 | $2,420 | -99.6% | 61,140 | +383.5% | 0.00% | – |
| Q2 2022 | $554,000 | -90.3% | 12,646 | -84.0% | 0.00% | -100.0% |
| Q1 2022 | $5,716,000 | -47.3% | 79,032 | -40.9% | 0.00% | -33.3% |
| Q4 2021 | $10,850,000 | -24.8% | 133,832 | +8.0% | 0.00% | -40.0% |
| Q3 2021 | $14,422,000 | -3.1% | 123,920 | +38.1% | 0.01% | 0.0% |
| Q2 2021 | $14,880,000 | +43.2% | 89,751 | +20.5% | 0.01% | +66.7% |
| Q1 2021 | $10,389,000 | +167.3% | 74,476 | +231.7% | 0.00% | +200.0% |
| Q4 2020 | $3,887,000 | +36.5% | 22,454 | +9.9% | 0.00% | 0.0% |
| Q3 2020 | $2,847,000 | +53.6% | 20,435 | +31.7% | 0.00% | 0.0% |
| Q2 2020 | $1,854,000 | +9.6% | 15,520 | -8.2% | 0.00% | 0.0% |
| Q1 2020 | $1,691,000 | – | 16,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |